https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Targeting eosinophils in respiratory diseases: biological axis, emerging therapeutics and treatment modalities https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:46370 Wed 16 Nov 2022 08:45:58 AEDT ]]> Rutin-loaded liquid crystalline nanoparticles attenuate oxidative stress in bronchial epithelial cells: A PCR validation https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:53640 Wed 13 Dec 2023 10:34:07 AEDT ]]> Perfluorocarbons therapeutics in modern cancer nanotechnology for hypoxia-induced anti-tumor therapy https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:53709 Wed 10 Jan 2024 11:02:51 AEDT ]]> Small interfering RNA for cancer treatment: overcoming hurdles in delivery https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:43998 Wed 05 Oct 2022 15:10:41 AEDT ]]> Hypoxia-inducible factor (HIF): Fuel for cancer progression https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:53287 Tue 21 Nov 2023 10:23:37 AEDT ]]> Probing 3CL protease: Rationally designed chemical moieties for COVID-19 https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:41952 Tue 16 Aug 2022 14:38:19 AEST ]]> Hybrid molecules based on 1,3,5-triazine as potential therapeutics: a focused review https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:39877 Thu 14 Jul 2022 13:40:35 AEST ]]>